Detection methods of circulating tumor cells.
作者信息
Pantel Klaus, Alix-Panabières Catherine
机构信息
Department of Tumour Biology, Centre of Experimental Medicine, University Cancer Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany;
出版信息
J Thorac Dis. 2012 Oct;4(5):446-7. doi: 10.3978/j.issn.2072-1439.2012.08.15.
Abstract
摘要
相似文献
1
Detection methods of circulating tumor cells.
J Thorac Dis. 2012 Oct;4(5):446-7. doi: 10.3978/j.issn.2072-1439.2012.08.15.
2
Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Adv Clin Chem. 2018;83:121-181. doi: 10.1016/bs.acc.2017.10.004. Epub 2017 Dec 21.
3
CTC enumeration and characterization: moving toward personalized medicine.
Ann Transl Med. 2014 Nov;2(11):108. doi: 10.3978/j.issn.2305-5839.2014.09.06.
4
Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials.
Per Med. 2014 Jul;11(5):545-558. doi: 10.2217/pme.14.30.
5
Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
Crit Rev Oncol Hematol. 2019 Dec;144:102827. doi: 10.1016/j.critrevonc.2019.102827. Epub 2019 Nov 2.
6
Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?
Ann Transl Med. 2014 Nov;2(11):107. doi: 10.3978/j.issn.2305-5839.2014.08.11.
7
Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Tumour Biol. 2017 Mar;39(3):1010428317695915. doi: 10.1177/1010428317695915.
8
Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer.
Cancers (Basel). 2020 Jun 13;12(6):1566. doi: 10.3390/cancers12061566.
9
Role of circulating tumor DNA in the management of patients with colorectal cancer.
Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):396-402. doi: 10.1016/j.clinre.2018.03.002. Epub 2018 Apr 5.
10
The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: from Enumeration to Molecular Characterization.
Curr Breast Cancer Rep. 2014 Sep;6(3):146-153. doi: 10.1007/s12609-014-0149-9.
引用本文的文献
1
Single Cell Transcriptome in Colorectal Cancer-Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells.
Front Pharmacol. 2020 Feb 27;11:135. doi: 10.3389/fphar.2020.00135. eCollection 2020.
2
Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer.
Cell Oncol (Dordr). 2020 Feb;43(1):31-49. doi: 10.1007/s13402-019-00470-y. Epub 2019 Dec 11.
3
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
BMC Cancer. 2019 Apr 3;19(1):304. doi: 10.1186/s12885-019-5528-1.
4
Using circulating tumor cells to advance precision medicine in prostate cancer.
J Cancer Metastasis Treat. 2017;3:190-205. doi: 10.20517/2394-4722.2017.45. Epub 2017 Sep 27.
5
The dawn of the liquid biopsy in the fight against cancer.
Oncotarget. 2017 Dec 8;9(2):2912-2922. doi: 10.18632/oncotarget.23131. eCollection 2018 Jan 5.
6
Advances in microfluidic devices made from thermoplastics used in cell biology and analyses.
Biomicrofluidics. 2017 Oct 24;11(5):051502. doi: 10.1063/1.4998604. eCollection 2017 Sep.
7
Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology.
Mol Ther Nucleic Acids. 2017 Sep 15;8:542-557. doi: 10.1016/j.omtn.2017.08.004. Epub 2017 Aug 12.
8
Gene expression profiling and DNA methylation analyses of CTCs.
Mol Oncol. 2016 Mar;10(3):431-42. doi: 10.1016/j.molonc.2016.01.011. Epub 2016 Feb 5.
9
Prognostic relevance of minimal residual disease in colorectal cancer.
World J Gastroenterol. 2014 Aug 14;20(30):10296-304. doi: 10.3748/wjg.v20.i30.10296.
10
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients.
Biomed Res Int. 2014;2014:415721. doi: 10.1155/2014/415721. Epub 2014 May 8.
本文引用的文献
1
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.
Int J Oncol. 2012 Oct;41(4):1241-50. doi: 10.3892/ijo.2012.1557. Epub 2012 Jul 16.
2
Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector.
Sci Transl Med. 2012 Jul 4;4(141):141ra92. doi: 10.1126/scitranslmed.3003747.
3
Plasticity of disseminating cancer cells in patients with epithelial malignancies.
Cancer Metastasis Rev. 2012 Dec;31(3-4):673-87. doi: 10.1007/s10555-012-9370-z.
4
EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.
Recent Results Cancer Res. 2012;195:69-76. doi: 10.1007/978-3-642-28160-0_6.
5
A novel platform for detection of CK+ and CK- CTCs.
Cancer Discov. 2011 Dec;1(7):580-6. doi: 10.1158/2159-8290.CD-11-0215. Epub 2011 Nov 3.
6
Circulating tumor cells and circulating tumor DNA.
Annu Rev Med. 2012;63:199-215. doi: 10.1146/annurev-med-062310-094219. Epub 2011 Nov 2.
7
Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Clin Chem. 2011 Sep;57(9):1242-55. doi: 10.1373/clinchem.2011.165068. Epub 2011 Jul 22.
8
Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.
Clin Chem. 2011 Mar;57(3):421-30. doi: 10.1373/clinchem.2010.154328. Epub 2011 Jan 18.
9
Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept.
Cytometry B Clin Cytom. 2011 Mar;80(2):100-11. doi: 10.1002/cyto.b.20560. Epub 2010 Oct 15.
10
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7. doi: 10.1073/pnas.1012539107. Epub 2010 Oct 7.
Zotero 插件